Journal der Deutschen Dermatologischen Gesellschaft
Journal Abbreviation: J DTSCH DERMATOL GES
ISSN: 1610-0387
eISSN: 1610-0379
Publisher: Wiley-Blackwell
Publications (304)
The Neural Crest Transcription Factor SOX10 is essential for the Survival of Uveal Melanoma Cells (2020)
Wessely A, Kammerbauer C, Berking C, Heppt M
Conference contribution
3D Bioprinting of Melanoma Cells with commercially available Bio Inks (2020)
Schmidt S, Schmid R, Arkudas A, Kengelbach-Weigand A, Boßerhoff AK
Conference contribution
Step-by-step Improvement of mRNA-electroporated dendritic Cells in a Phase I / II Clinical Study in cutaneous Melanoma Patients: better Survival correlates with a higher Immunoscore and increased Expression of PEBP1 in the Blood (2020)
Dörrie J, Schaft N, Gross S, Ostalecki C, Eberhardt M, Vera-Gonzales J, Uslu U, et al.
Conference contribution
Malignant Tumors as important Differential Diagnosis of chronic Ulcers (2020)
Toussaint F, Erdmann M, Berking C, Erfurt-Berge C
Conference contribution
Detection and Assessment of epidermotropic, pigmented Melanoma Metastases under Therapy using 3D Whole-Body Photography (2020)
Erdmann M, Toussaint F, Hornung A, Heinzerling L, Berking C, Schliep S
Conference contribution
COVID-19 und Auswirkungen auf dermatologische und allergologische Erkrankungen (2020)
Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, et al.
Journal article, Review article
COVID-19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen (2020)
Schön MP, Berking C, Biedermann T, Buhl T, Erpenbeck L, Eyerich K, Eyerich S, et al.
Journal article, Review article
Infektiöse Reisedermatosen (2020)
Rongisch R, Schmidt E, Deresz N, Deresz K, Schöfer H, Schäkel K, Jakob T, et al.
Journal article
Side effect management during immune checkpoint blockade using CTLA-4 and PD-1 antibodies for metastatic melanoma - an update (2020)
Kaehler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R
Journal article
Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom – ein Update (2020)
Kähler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R
Journal article